ARCTURUS THERAPEUTICS HOLDINGS INC. Equity Method Investments
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Equity Method Investments of $131.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:EquityMethodInvestments · last filed 2023-03-29
- 2022-03-31: Equity Method Investments $131.00K.
- 2021-12-31: Equity Method Investments $515.00K.
- 2021-09-30: Equity Method Investments $670.00K.
- 2021-06-30: Equity Method Investments $920.00K.
| Period end | Equity Method Investments |
|---|---|
| 2022-03-31 | $131.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $515.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $670.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $920.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.25M 10-Q · filed 2021-05-10 |
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $263.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $303.00K 10-Q · filed 2019-11-08 |
| 2018-12-31 | $288.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |